EPOGEN for Nephrogenic anaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where EPOGEN was used for Nephrogenic anaemia.
Most Reported Side Effects for EPOGEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Incorrect product storage | 35 | 23.0% | 0 | 0 |
| Haemoglobin decreased | 20 | 13.2% | 0 | 3 |
| Drug ineffective | 11 | 7.2% | 0 | 0 |
| Medication error | 11 | 7.2% | 0 | 0 |
| Aplasia pure red cell | 9 | 5.9% | 0 | 3 |
| Haemoglobin abnormal | 9 | 5.9% | 0 | 0 |
| Anaemia | 8 | 5.3% | 0 | 3 |
| Therapeutic response decreased | 7 | 4.6% | 0 | 0 |
| Drug hypersensitivity | 6 | 4.0% | 0 | 0 |
| Pruritus | 6 | 4.0% | 0 | 0 |
| Death | 5 | 3.3% | 5 | 0 |
Other Indications for EPOGEN
Other Drugs Used for Nephrogenic anaemia
DARBEPOETIN ALFA (5,332)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331)
ARANESP (1,740)
DAPRODUSTAT (859)
ERYTHROPOIETIN (750)
PEGZEREPOETIN ALFA (325)
EPOETIN ALFA-EPBX (169)
VADADUSTAT (140)
MIRCERA (100)
ENARODUSTAT (66)